Woodberry International Publishing to Launch “Kid’s Zombie Adventures Series: Escape from Camp Miccano” – ISBN : 978-0-9916537-1-3

By Woodberry International Publishing You may find this book by using ISBN 978-0-9916537-1-3. [PR.com] …read more

Source:: Pr.Com – United States

      

Franchise Beacon to Attend the West Coast Franchise Expo

By Franchise Beacon Franchise Beacon announces that they will be attending the West Coast Franchise Exposition in Anaheim, California. [PR.com] …read more

Source:: Pr.Com – United States

      

Golden Collar Awards Creator and Pet-Friendly Companies to Create Life Saving Programs

By Golden Collar Entertainment Alan Siskind, creator of the Golden Collar Awards, and Golden Collar Entertainment LLC, have launched Profiting From Pets, a life-saving cause marketing company. Profiting from Pets works closely with national pet-friendly retailers and consumer companies to develop sales and brand loyalty programs targeting their pet owning customers. A portion of the revenues generated from these programs will be used to support no kill [PR.com] …read more

Source:: Pr.Com – United States

      

Where next for mining’s dominant emerging markets?

Emerging market companies are drastically outperforming their counterparts from the developed world and becoming increasingly dominant in the industry. Emerging markets still pose familiar risks, but with emerging market miners now filling up the maj… …read more

Source:: Net Resources International – Mining Technology

      

Theravance reports positive data from Anoro Ellipta’s third lung function trial in COPD

Theravance has reported positive results from a third lung function trial of Anoro Ellipta (umeclidinium /vilanterol, UMEC/VI) with the LAMA tiotropium, administered in the HandiHaler inhaler, in patients with chronic obstructive pulmonary disease (C… …read more

Source:: Net Resources International – Drug Development Technology

      

Regeneron and Sanofi initiate Phase III trial of dupilumab to treat atopic dermatitis

Regeneron Pharmaceuticals and Sanofi have started dosing patients in a Phase III clinical trial of dupilumab, an investigational therapy that blocks IL-4 and IL-13 signaling, in adults with moderate-to-severe atopic dermatitis (AD). …read more

Source:: Net Resources International – Drug Development Technology

      

Fonterra joins hands with MFAT to enhance dairy production in developing countries

New Zealand-based co-operative dairy Fonterra will be working together with the Ministry of Foreign Affairs and Trade (MFAT) to help developing countries increase their dairy nutrition knowledge. …read more

Source:: Net Resources International – Food Processing Technology

      

US EPA funds water projects in New York, New Jersey and Puerto Rico

The US Environmental Protection Agency (EPA) has provided $197m in funds to New York, $74m to New Jersey and $26.8m to Puerto Rico, in order to improve water infrastructure. …read more

Source:: Net Resources International – Water Technology